Aptose Biosciences Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
38.00
21.00
96.00
154.00
111.60
114.10
Gross Income
38.00
21.00
96.00
154.00
111.60
114.10
SG&A Expense
5,551.00
9,261.00
16,003.00
18,512.00
15,238.60
37,612.90
EBIT
5,589.00
9,282.00
16,099.00
18,666.00
15,350.30
37,727
Unusual Expense
-
1,088.00
-
-
-
-
Non Operating Income/Expense
-
-
1,230.00
66.00
125.90
57
Interest Expense
6.00
259.00
43.00
-
-
-
Pretax Income
5,565.00
10,553.00
14,626.00
18,627.00
15,136.10
37,417.20
Consolidated Net Income
5,565.00
10,553.00
14,626.00
18,627.00
15,136.10
37,417.20
Net Income
5,565.00
10,553.00
14,626.00
18,627.00
15,136.10
37,417.20
Net Income After Extraordinaries
5,565.00
10,553.00
14,626.00
18,627.00
15,136.10
37,417.20
Net Income Available to Common
5,565.00
10,553.00
14,626.00
18,627.00
15,136.10
37,417.20
EPS (Basic)
1.56
2.02
1.23
1.46
0.67
1.12
Basic Shares Outstanding
3,520.90
5,216.00
11,906.00
12,743.00
22,313.00
33,391
EPS (Diluted)
1.58
2.02
1.23
1.46
0.68
1.12
Diluted Shares Outstanding
3,520.90
5,216.00
11,906.00
12,743.00
22,313.00
33,391
EBITDA
5,551.00
9,261.00
16,003.00
18,512.00
15,238.60
37,612.90
Non-Operating Interest Income
30.00
76.00
286.00
105.00
88.30
366.80
About Aptose Biosciences
View Profile
